» Articles » PMID: 39192051

Integrative Genomic Analyses Identify Neuroblastoma Risk Genes Involved in Neuronal Differentiation

Overview
Journal Hum Genet
Specialty Genetics
Date 2024 Aug 27
PMID 39192051
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-Wide Association Studies (GWAS) have been decisive in elucidating the genetic predisposition of neuroblastoma (NB). The majority of genetic variants identified in GWAS are found in non-coding regions, suggesting that they can be causative of pathogenic dysregulations of gene expression. Nonetheless, pinpointing the potential causal genes within implicated genetic loci remains a major challenge. In this study, we integrated NB GWAS and expression Quantitative Trait Loci (eQTL) data from adrenal gland to identify candidate genes impacting NB susceptibility. We found that ZMYM1, CBL, GSKIP and WDR81 expression was dysregulated by NB predisposing variants. We further investigated the functional role of the identified genes through computational analysis of RNA sequencing (RNA-seq) data from single-cell and whole-tissue samples of NB, neural crest, and adrenal gland tissues, as well as through in vitro differentiation assays in NB cell cultures. Our results indicate that dysregulation of ZMYM1, CBL, GSKIP, WDR81 may lead to malignant transformation by affecting early and late stages of normal program of neuronal differentiation. Our findings enhance the understanding of how specific genes contribute to NB pathogenesis by highlighting their influence on neuronal differentiation and emphasizing the impact of genetic risk variants on the regulation of genes involved in critical biological processes.

References
1.
Park J, Bagatell R, Cohn S, Pearson A, Villablanca J, Berthold F . Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017; 35(22):2580-2587. PMC: 5676955. DOI: 10.1200/JCO.2016.72.0177. View

2.
Capasso M, McDaniel L, Cimmino F, Cirino A, Formicola D, Russell M . The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. J Cell Mol Med. 2017; 21(12):3224-3230. PMC: 5706517. DOI: 10.1111/jcmm.13226. View

3.
Atwal J, Massie B, Miller F, Kaplan D . The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron. 2000; 27(2):265-77. DOI: 10.1016/s0896-6273(00)00035-0. View

4.
Bosse K, Diskin S, Cole K, Wood A, Schnepp R, Norris G . Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res. 2012; 72(8):2068-78. PMC: 3328617. DOI: 10.1158/0008-5472.CAN-11-3703. View

5.
Cimmino F, Montella A, Tirelli M, Avitabile M, Lasorsa V, Visconte F . FGFR1 is a potential therapeutic target in neuroblastoma. Cancer Cell Int. 2022; 22(1):174. PMC: 9052553. DOI: 10.1186/s12935-022-02587-x. View